These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7656098)

  • 1. Intravenous histamine H2-receptor antagonists and parenteral nutrition: patterns of use.
    Bone BM; Maksym CJ; Kirking DM; Georgal BA; Jarvis CL; Dunn-Kucharski VA; Berardi RR
    Am J Health Syst Pharm; 1995 May; 52(10):1082-6. PubMed ID: 7656098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine receptor antagonists and lipid stability in total nutrient admixtures.
    Hatton J; Luer M; Hirsch J; Westrich T; Holstad S
    JPEN J Parenter Enteral Nutr; 1994; 18(4):308-12. PubMed ID: 7933436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.
    He Y; Chan EW; Man KK; Lau WC; Leung WK; Ho LM; Wong IC
    Drug Saf; 2014 Sep; 37(9):711-21. PubMed ID: 25096957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of direct pharmacist intervention on conversion from parenteral to oral histamine H2-receptor antagonist therapy.
    Kirking DM; Svinte MK; Berardi RR; Cornish LA; Chaffee BW; Ryan ML
    DICP; 1991 Jan; 25(1):80-4. PubMed ID: 1672572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and compatibility of histamine H2-receptor antagonists in parenteral nutrition mixtures.
    Puzovic M; Hardy G
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):311-7. PubMed ID: 17414500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of H
    Shim YK; Kim N
    Korean J Gastroenterol; 2017 Jul; 70(1):4-12. PubMed ID: 28728310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is important in treating elderly with H2 receptor antagonists].
    Kurosawa S
    Nihon Rinsho; 2002 Aug; 60(8):1613-7. PubMed ID: 12187760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule.
    Puig I; Calzado S; Suárez D; Sánchez-Delgado J; López S; Calvet X
    Pharmacol Res; 2012 Apr; 65(4):480-90. PubMed ID: 22289674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in prescribing patterns of intravenous histamine2-receptor antagonists results in significant cost savings without adversely affecting patient care.
    Fudge KA; Moore KA; Schneider DN; Sherrin TP; Wellman GS
    Ann Pharmacother; 1993 Feb; 27(2):232-7. PubMed ID: 8094986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of histamine (H2)-receptor antagonists in total parenteral nutrition patients.
    Baptista RJ
    Am J Med; 1987 Dec; 83(6A):53-7. PubMed ID: 2892408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?
    Hashimoto H; Kushikata T; Kudo M; Hirota K
    J Gastroenterol; 2007 Apr; 42(4):275-8. PubMed ID: 17464455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
    Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
    Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal disease control after histamine2-receptor antagonist dose modification for renal impairment in frail chronically ill elderly patients.
    Lackner TE; Heard T; Glunz S; Gann N; Babington M; Malone DC
    J Am Geriatr Soc; 2003 May; 51(5):650-6. PubMed ID: 12752840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.